117 related articles for article (PubMed ID: 32603003)
1. Radioiodinated estradiol dimer for estrogen receptor targeted breast cancer imaging.
Xu D; Peng C; Gao F; Guo Z; Zhuang R; Su X; Zhang X
Chem Biol Drug Des; 2020 Dec; 96(6):1332-1340. PubMed ID: 32603003
[TBL] [Abstract][Full Text] [Related]
2.
Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
[TBL] [Abstract][Full Text] [Related]
3. Radioiodinated 4-(
Xu D; Lin X; Zeng X; Wen X; Li J; Li Y; Huang J; Chen X; Guo Z; Zhang X
Anal Chem; 2021 Oct; 93(41):13998-14006. PubMed ID: 34612624
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
[TBL] [Abstract][Full Text] [Related]
5.
Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X
Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study of bio-distribution and tumor imaging of 131I in nude mice bearing human breast cancer].
Fan W; Wang GH; Yang MT; Zhang WG; Dai JJ; Yang XC
Ai Zheng; 2004 Jul; 23(7):808-11. PubMed ID: 15248917
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R
Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and application of 131I-fulvestrant as a targeted radiation drug for endocrine therapy in human breast cancer.
Yin G; Zeng B; Peng Z; Liu Y; Sun L; Liu C
Oncol Rep; 2018 Mar; 39(3):1215-1226. PubMed ID: 29328488
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
[TBL] [Abstract][Full Text] [Related]
10. Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues.
Yang DJ; Li C; Kuang LR; Price JE; Buzdar AU; Tansey W; Cherif A; Gretzer M; Kim EE; Wallace S
Life Sci; 1994; 55(1):53-67. PubMed ID: 8015349
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, estrogen receptor binding, and tissue distribution of a new iodovinylestradiol derivative (17alpha,20E)-21-[123I]Iodo-11beta-nitrato-19-norp regna-1,3,5 (10),20-tetraene-3,17-diol (E-[123I]NIVE).
Rijks LJ; van den Bos JC; van Doremalen PA; Boer GJ; de Bruin K; Doornbos T; Vekemans JA; Posthumus MA; Janssen AG; van Royen EA
Nucl Med Biol; 1998 May; 25(4):411-21. PubMed ID: 9639304
[TBL] [Abstract][Full Text] [Related]
12. [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
Paquette M; Ouellet R; Archambault M; Croteau É; Lecomte R; Bénard F
Nucl Med Biol; 2012 Jan; 39(1):57-64. PubMed ID: 22079037
[TBL] [Abstract][Full Text] [Related]
13. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
[TBL] [Abstract][Full Text] [Related]
14. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780).
Seimbille Y; Bénard F; Rousseau J; Pepin E; Aliaga A; Tessier G; van Lier JE
Nucl Med Biol; 2004 Aug; 31(6):691-8. PubMed ID: 15246359
[TBL] [Abstract][Full Text] [Related]
15. Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers.
Nayak TK; Hathaway HJ; Ramesh C; Arterburn JB; Dai D; Sklar LA; Norenberg JP; Prossnitz ER
J Nucl Med; 2008 Jun; 49(6):978-86. PubMed ID: 18483091
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader.
Heidari P; Deng F; Esfahani SA; Leece AK; Shoup TM; Vasdev N; Mahmood U
Clin Cancer Res; 2015 Mar; 21(6):1340-7. PubMed ID: 25609068
[TBL] [Abstract][Full Text] [Related]
17. [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.
Bénard F; Ahmed N; Beauregard JM; Rousseau J; Aliaga A; Dubuc C; Croteau E; van Lier JE
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1473-9. PubMed ID: 18360749
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging.
Aliaga A; Rousseau JA; Ouellette R; Cadorette J; van Lier JE; Lecomte R; Bénard F
Nucl Med Biol; 2004 Aug; 31(6):761-70. PubMed ID: 15246367
[TBL] [Abstract][Full Text] [Related]
19. One-Step
Huang H; Li K; Lv G; Liu G; Zhao X; Liu Q; Wang S; Li X; Qiu L; Lin J
Contrast Media Mol Imaging; 2018; 2018():5362329. PubMed ID: 29692688
[TBL] [Abstract][Full Text] [Related]
20. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]